| Literature DB >> 26089938 |
Jun-Xuan Yang1, Shen Wu2, Xi-Liang Huang3, Xiao-Quan Hu4, Yi Zhang5.
Abstract
Objective. To evaluate the hypolipidemic activity and antiatherosclerotic effect of polysaccharide of Polygonatum sibiricum (PPGS), which is a kind of Chinese herbal medicine using the rhizome part of the whole herb. Materials and Methods. Thirty rabbits were divided into normal control group, model control group, and PPGS subgroups of 0.8, 1.6, and 3.2 mL/kg/day under random selection. In atherosclerosis model, the effects of PPGS on diverse blood lipids, foam cells number, and aortic morphology were evaluated. In the primary culture of endothelial cells (ECs), the activities of PPGS on both ECs proliferation and ECs injury were studied as well. Results. In atherosclerosis model, the hypolipidemic activities of PPGS were mainly focused on TC, LDL-C, and Lp(a). All changes on these factors were statistically significant compared with model group (P < 0.01), except TG and HDL-C. The intimal foam cell number of PPGS subgroups (0.8, 1.6, and 3.2 mL/kg/day) was significantly reduced than model control (P < 0.01). In the primary culture of endothelial cells (ECs), PPGS showed no effect on cell proliferation but preferred to protect EC from injury and apoptosis induced by H2O2 and lipopolysaccharide (LPS). Discussion and Conclusion. The antiatherosclerotic effect of PPGS may be supported by its hypolipidemic activities, improving aortic morphology, and reducing foam cells number and ECs injury.Entities:
Year: 2015 PMID: 26089938 PMCID: PMC4451159 DOI: 10.1155/2015/391065
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
The hypolipidemic effects of PPGS in atherosclerosis rabbit model (n = 6).
| Groups | TC | LDL-C | Lp(a) | |||
|---|---|---|---|---|---|---|
| Before | After | Before | After | Before | After | |
| Normal control | 1.26 ± 0.25 | 1.40 ± 0.33 | 1.18 ± 0.26 | 1.26 ± 0.17 | 50.41 ± 10.33 | 67.32 ± 15.13 |
| Model control | 1.24 ± 0.31 | 12.18 ± 2.40 | 1.17 ± 0.24 | 10.46 ± 1.53 | 47.35 ± 15.16 | 643.72 ± 151.69 |
| PPGS (0.8 mL/kg/day) | 1.31 ± 0.40 | 7.82 ± 4.13∗∗ | 1.20 ± 0.31 | 6.42 ± 3.48∗∗ | 49.52 ± 8.82 | 81.40 ± 26.73∗∗ |
| PPGS (1.6 mL/kg/day) | 1.38 ± 0.41 | 5.81 ± 1.92∗∗ | 1.25 ± 0.27 | 4.61 ± 1.56∗∗ | 51.9 ± 14.83 | 47.36 ± 15.39∗∗ |
| PPGS (3.2 mL/kg/day) | 1.32 ± 0.37 | 4.5 ± 2.11∗∗ | 1.22 ± 0.25 | 3.45 ± 0.73∗∗ | 46.68 ± 14.81 | 33.52 ± 12.68∗∗ |
Note: compared with model control group, ∗∗ P < 0.01.
Figure 1Microscope camera drawing of HE staining on rabbit thoracic aorta (200x): (a) normal group; (b) model control group; (c) 3.2 mL/kg/day PPGS group.
Figure 2The effects of PPGS after being administered continuously for 8 weeks on foam cells number in atherosclerosis rabbit model (n = 6).
Figure 3The impact of PPGS on EC injury and related cytokines releasing (n = 6).
Figure 4The impact of PPGS on EC injury and apoptotic condition (n = 6).
The effects of PPGS on HUASMCs proliferation and migration (n = 6).
| Groups | OD values | Cells migration number 24 h | ||
|---|---|---|---|---|
| 12 h | 24 h | 48 h | ||
| Normal control | 0.186 ± 0.024 | 0.202 ± 0.022 | 0.215 ± 0.027 | 39.1 ± 4.2 |
| PPGS (0.3 mg/kg) | 0.172 ± 0.020 | 0.171 ± 0.024∗ | 0.177 ± 0.019∗ | 35.8 ± 4.6 |
| PPGS (0.6 mg/kg) | 0.159 ± 0.022∗ | 0.162 ± 0.017∗∗ | 0.169 ± 0.015∗∗ | 33.2 ± 4.3∗ |
| PPGS (1.2 mg/kg) | 0.138 ± 0.015∗ | 0.141 ± 0.015∗∗ | 0.155 ± 0.018∗∗ | 30.6 ± 4.1∗∗ |
Note: compared with model control group, ∗ P < 0.05 and ∗∗ P < 0.01.
Figure 5The crystal violet staining of HUASMCs on each group: (a) 1.2 mg/kg PPGS subgroup and (b) control group (200x).